Compare Edwards Lifesciences Corporation Common Stock (EW) vs Wynn Resorts, Limited (WYNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Wynn Resorts, Limited — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $83.84 (market cap $48.56B), while Wynn Resorts, Limited trades at $75.47 (market cap $7.75B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 6.3× Wynn Resorts, Limited's market cap, and Wynn Resorts, Limited pays a 1.33% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| EW | WYNN | |
|---|---|---|
Market Cap | $48.56B | $7.75B |
Volume | 6,520,488 | 2,243,813 |
Sector | Health | Consumer Cyclical |
52-Week High | $95.18 | $133.09 |
52-Week Low | $72.65 | $74.97 |
Enterprise Value | $45.01B | $17.99B |
Typical Hold Time | — | 76 Days |
Dividend Yield | — | 1.33% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Wynn Resorts (WYNN) trades at $74.97, down 2.15% today, with a bearish technical signal despite bullish oscillators. The company reported mixed Q2 2026 results, beating EPS estimates but facing margin pressures. Revenue reached $7.14B in 2025, though net income declined to $327M. Analysts maintain a strong buy consensus with a $132.36 price target, while institutional activity shows mixed positioning amid high debt levels and significant capital expenditure plans.
The outlook for WYNN hinges on Macau recovery and successful execution of UAE expansion, but rising capex and debt servicing costs pose risks. Current valuation metrics appear reasonable with P/E of 18.06 and EV/EBITDA of 9.23, though investors should monitor margin trends and project timelines closely given the stock's significant discount to analyst targets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Wynn Resorts, Limited
Wynn Resorts operates luxury casinos and resorts. The company was founded in 2002 by Steve Wynn, the former CEO. The company operates four megaresorts: Wynn Macau and Encore in Macao and Wynn Las Vegas and Encore in Las Vegas. Cotai Palace opened in August 2016 in Macao, Encore Boston Harbor in Massachusetts opened June 2019. Additionally, we expect the company to begin construction on a new building next to its existing Macao Palace resort in 2023, which we forecast to open in 2026. The company also operates Wynn Interactive, a digital sports betting and iGaming platform. The company received 76% and 24% of its 2019 prepandemic EBITDA from Macao and Las Vegas, respectively.
Read more on WYNN →
